Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Positive test for Bayer deep vein thrombosis drug
The two dose-finding studies included more than 1,300 patients and demonstrated safety and efficacy for BAY 59-7939 similar to the current gold standard enoxaparin, a low molecular weight
The two dose-finding studies included more than 1,300 patients and demonstrated safety and efficacy for BAY 59-7939 similar to the current gold standard enoxaparin, a low molecular weight
Under the terms of the agreement, Sepracor shareholders will receive $23 in cash for each share of Sepracor they own for a total transaction value of approximately $2.6
Geron’s increasing revenues was said to be largely down to the receipt of an upfront payment of $4 million in conjunction with the transfer of intellectual property rights
For about a decade, scientists have recognized that many cases of hereditary breast cancer result from a mutation of a specific gene called BRCA1, which, in its normal
The specialty pharmaceutical company’s failure to file these periodic reports violated Nasdaq Marketplace Rules, compliance with which is required for continued listing. The de-listing became effective at the
Teva received an approvable letter from the FDA regarding Agilect (rasagiline) in July 2004, and has since submitted additional data to the agency which it believed resolved the
Cell migration belongs to the most rudimentary of cellular functions that allow processes such as fetal development, new blood vessel formation and wound healing to occur in humans.
Over the past decade, DNA sequencing costs have fallen more than 50-fold, fueled in large part by tools, technologies and process improvements developed as part of the successful
Arterio-venous malformations (AVMs) are abnormal blood vessel networks that result in unusually high blood flow between arteries and veins in the brain. The resulting pressure imbalances caused by
Halobetasol cream is a bioequivalent of Bristol-Myers Squibb’s Ultravate cream, a super-high potency prescription topical corticosteroid product used primarily for the treatment of inflammatory skin conditions. According to